Kumaran D.
- Country
- France
- Department
- Service Nephrologie pediatrique
Research Overview
- Pharmacokinetic, Safety, Tolerability, Immunogenicity and Pharmacodynamic Evaluation of Subcutaneous Ocrelizumab in Pediatric Relapsing‑Remitting Multiple Sclerosis
- Phase III Multicenter Open-Label Trial Evaluating Rituximab Efficacy in Psychiatric Disorders with Autoimmunity
- Evaluation of Immediate Versus Delayed Azathioprine or Rituximab Therapy in Pediatric Anti-MOG Antibody-Associated Acute Demyelinating Syndromes
Data & Insights
Has run more than one trial at 37 of 95 partner sites.
Specializations
Neuroinflammatory Disorders
The investigator specializes in treating neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), with particular focus on pediatric manifestations.
- NMOSD therapeutic interventions
- MOGAD treatment strategies
- Pediatric neuroimmunology
Clinical expertise extends to evaluating novel therapeutic approaches for these rare neuroimmune conditions.
Multiple Sclerosis Research
Dedicated to advancing treatment options for pediatric multiple sclerosis, with expertise in comparing various therapeutic agents and their long-term outcomes.
- Pediatric MS management
- Immunomodulatory therapies
- Cognitive function assessment
Focuses on evaluating treatment efficacy in young MS patients, including developmental considerations.
Neurological Complications
Investigates childhood stroke and focal cerebral arteriopathy, with emphasis on inflammatory conditions affecting cerebral vessels.
- Pediatric stroke treatment
- Anti-inflammatory interventions
- Arteriopathy management
Studies innovative approaches to treating inflammatory vessel wall diseases in children.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.